title: Advisory statement on clinical use of modified aortic endografts from the Society for Vascular Surgery®.
authors: David Geffen UCLA School of Medicine, University of California, Los Angeles, CA, USA. rawhite@ucla.edu
authors: Rodney A
authors: RA
authors: White
mesh_terms: D001011:Aorta / Q000601:surgery*; D001807:Blood Vessel Prosthesis / Q000592:standards; D019917:Blood Vessel Prosthesis Implantation / Q000009:adverse effects / Q000295:instrumentation* / Q000331:legislation & jurisprudence / Q000592:standards; D057176:Compassionate Use Trials; D018795:Device Approval / Q000331:legislation & jurisprudence / Q000592:standards; D004059:Diffusion of Innovation; D057510:Endovascular Procedures / Q000009:adverse effects / Q000295:instrumentation* / Q000331:legislation & jurisprudence / Q000592:standards; D019317:Evidence-Based Medicine; D006801:Humans; D061214:Patient Safety; D017410:Practice Guidelines as Topic; D011474:Prosthesis Design; D018570:Risk Assessment; D012307:Risk Factors; D012955:Societies, Medical; D015607:Stents / Q000592:standards; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence / Q000592:standards